Asarfi Hospital Ltd
Incorporated in 2005, Asarfi Hospital Ltd
provides primary health services & treatment
and specialized super speciality health service[1]
- Market Cap ₹ 422 Cr.
- Current Price ₹ 214
- High / Low ₹ 257 / 118
- Stock P/E 23.3
- Book Value ₹ 52.2
- Dividend Yield 0.00 %
- ROCE 18.8 %
- ROE 19.0 %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
- Company has delivered good profit growth of 37.1% CAGR over last 5 years
- Company's working capital requirements have reduced from 24.3 days to 19.2 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| 43 | 54 | 65 | 69 | 81 | 116 | 173 | 183 | |
| 37 | 46 | 54 | 55 | 65 | 93 | 138 | 147 | |
| Operating Profit | 6 | 8 | 11 | 14 | 16 | 24 | 36 | 36 |
| OPM % | 15% | 15% | 17% | 20% | 20% | 20% | 20% | 20% |
| 0 | 0 | 1 | 2 | 2 | 8 | 3 | 4 | |
| Interest | 1 | 1 | 1 | 1 | 3 | 4 | 4 | 4 |
| Depreciation | 2 | 3 | 3 | 4 | 9 | 13 | 11 | 12 |
| Profit before tax | 4 | 5 | 8 | 11 | 6 | 15 | 23 | 24 |
| Tax % | 27% | 26% | 26% | 26% | 33% | 25% | 24% | |
| 3 | 4 | 6 | 8 | 4 | 11 | 17 | 18 | |
| EPS in Rs | 21.48 | 28.83 | 46.79 | 5.53 | 2.14 | 5.58 | 8.68 | 9.22 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 26% |
| 3 Years: | 36% |
| TTM: | 36% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 37% |
| 3 Years: | 29% |
| TTM: | 43% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 18% |
| 1 Year: | 72% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 17% |
| 3 Years: | 14% |
| Last Year: | 19% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 14 | 20 | 20 | 20 |
| Reserves | 12 | 16 | 21 | 27 | 51 | 62 | 79 |
| 5 | 7 | 12 | 17 | 32 | 49 | 58 | |
| 9 | 13 | 28 | 34 | 52 | 34 | 38 | |
| Total Liabilities | 28 | 37 | 63 | 93 | 154 | 164 | 194 |
| 18 | 22 | 31 | 39 | 94 | 101 | 108 | |
| CWIP | 0 | 2 | 9 | 18 | 0 | 2 | 2 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 9 | 13 | 22 | 37 | 60 | 61 | 84 | |
| Total Assets | 28 | 37 | 63 | 93 | 154 | 164 | 194 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 2 | 10 | 9 | 7 | 26 | -4 | 19 | |
| -5 | -16 | -23 | -21 | -63 | -8 | -19 | |
| 2 | 6 | 14 | 15 | 36 | 13 | 5 | |
| Net Cash Flow | 0 | 0 | -0 | 1 | -1 | 1 | 5 |
| Free Cash Flow | -5 | 2 | -10 | -13 | -20 | -14 | 1 |
| CFO/OP | 62% | 142% | 104% | 73% | 162% | -3% | 69% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 20 | 14 | 30 | 90 | 109 | 125 | 114 |
| Inventory Days | 23 | 13 | 16 | 26 | 32 | 30 | 30 |
| Days Payable | 156 | 23 | 34 | 91 | 445 | 171 | 156 |
| Cash Conversion Cycle | -113 | 5 | 11 | 25 | -304 | -16 | -12 |
| Working Capital Days | -10 | -38 | -36 | 18 | 3 | 50 | 19 |
| ROCE % | 25% | 29% | 26% | 11% | 16% | 19% |
Insights
In beta| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Inpatient Volume (IPD) Patients |
|
||||
| Outpatient Volume (OPD) Patients |
|||||
| Super Specialty Hospital ARPOB INR per occupied bed per day |
|||||
| Super Specialty Hospital Occupancy Rate % |
|||||
| Total Bed Capacity Beds |
|||||
| Cancer Hospital ARPOB INR per occupied bed per day |
|||||
| Cancer Hospital Occupancy Rate % |
|||||
| Total Surgery Count Surgeries |
|||||
Extracted by Screener AI
Documents
Announcements
- Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (LODR), 2015.
-
Board Meeting Intimation for Notice Of 21St Annual General Meeting Of Asarfi Hospital Limited.
- Board to meet 25 Aug 2026; may discuss SME-to-main-board and NSE migration.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
- Q1 FY27 unaudited standalone and consolidated results published; revenue ₹4,734.47 lakh, PAT ₹426.84 lakh.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
- Q1 FY27 revenue rose 33% to ₹4,734.47 lakh; PAT increased to ₹426.84 lakh.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
- We hereby submit the Investor Presentation for the Qtr ended 30th June 2026.
Concalls
-
Aug 2026TranscriptAI SummaryPPT
-
May 2026Transcript PPT
-
Feb 2026TranscriptAI SummaryPPT
-
Nov 2025Transcript PPT
-
Aug 2025TranscriptAI SummaryPPT
-
May 2025Transcript PPT
-
Jan 2025TranscriptAI SummaryPPT
-
Nov 2024Transcript PPT
Business Overview:
Asarfi Hospital operates 3 primary facilities:
a) Super Multi-Specialty Hospital (Baramuri, Dhanbad):[1]
The Co. operates a Super-Specialty Hospital
is the first and only super-specialty facility in
the Dhanbad region, offering 23+ specialized services under one roof. It provides advanced critical care, emergency care, cardiac care, diagnostics, and multi-specialty treatments.
b) Asarfi Cancer Institute (Ranguni, Dhanbad)[2]
- Location and Size:
Built on 9.55 acres of leased land from the Jharkhand Industrial Area Development Authority (JIADA).
- Capacity and Occupancy:
Currently, the Cancer Institute operates with
65 beds across two floors, achieving an average occupancy rate of 42% as of FY26. It Plans are underway to expand capacity to 150 beds with an additional investment of ₹2-3 crores.
- Unique Positioning:
It is the only dedicated cancer hospital within a 200 km radius, offering specialized oncology services including medical, surgical, and radiation oncology.
- Future Expansion:
The facility is approved for construction of up
to seven floors, enabling substantial expansion.
c) Research Institute (Ranchi):[3]
- Location and Infrastructure: Located 4 km from Ranchi Airport, in proximity to HEC India, on 5.6 acres of acquired land for 13.5 Crs
- Development Plans: AHL plans to establish medical and non-medical research management courses by FY28. The land’s value has appreciated since its acquisition, estimated at ₹65 crores.